Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 559.65
-0.367 %
$ 214 B
Market Cap
35.09
P/E
TMO - STOCK-BASED COMPENSATION
Stock-based Compensation TMO - Thermo Fisher Scientific Inc.
278 M
LAST VALUE
9.94%
2 YEAR CAGR
8.96%
5 YEAR CAGR
11.83%
10 YEAR CAGR